David W. Hecht
M.D., IDSA
John W. Clarke Professor of Medicine
Department Chairperson, Medicine
Infectious Disease
Microbiology and Immunology
CONTACT INFORMATION
Specialties
HIV, General Infectious Disease, AIDS
Locations
Board Certifications
Infectious Disease - Subspecialty Cert: AM Board of Internal Medicine
Internal Medicine - General Cert: AM Board of Internal Medicine
Publications
The novel antibacterial drug XF-70 is a potent inhibitor of Staphylococcus aureus infection of the burn wound.Hurtuk,M. G.; He,L. K.; Szilagyi,A.; Gamelli,R. L.; Hecht,D. W.; Kennedy,R. H.; Rhys-Williams,W.; Love,W. G.; Shankar,R.JOURNAL OF BURN CARE & RESEARCH 2010 ;31(3):462-469
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).Snydman,D. R.; Jacobus,N. V.; McDermott,L. A.; Golan,Y.; Hecht,D. W.; Goldstein,E. J.; Harrell,L.; Jenkins,S.; Newton,D.; Pierson,C.; Rihs,J. D.; Yu,V. L.; Venezia,R.; Finegold,S. M.; Rosenblatt,J. E.; Gorbach,S. L.CLINICAL INFECTIOUS DISEASES 2010 ;50(Suppl 1):S26-33
Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment.Johnson,S.; Schriever,C.; Patel,U.; Patel,T.; Hecht,D. W.; Gerding,D. N.ANAEROBE 2009 ;15(6):290-291
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.O'Connor,J. R.; Galang,M. A.; Sambol,S. P.; Hecht,D. W.; Vedantam,G.; Gerding,D. N.; Johnson,S.Antimicrobial Agents & Chemotherapy 2008 ;52(8):2813-2817
Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.Sears,C. L.; Islam,S.; Saha,A.; Arjumand,M.; Alam,N. H.; Faruque,A. S.; Salam,M. A.; Shin,J.; Hecht,D.; Weintraub,A.; Sack,R. B.; Qadri,F.CLINICAL INFECTIOUS DISEASES 2008 ;47(6):797-803
Interaction of Bacteroides fragilis pLV22a relaxase and transfer DNA with Escherichia coli RP4-TraG coupling protein.Thomas,J.; Hecht,D. W.MOLECULAR MICROBIOLOGY 2007 ;66(4):948-960
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.Hecht,D. W.; Galang,M. A.; Sambol,S. P.; Osmolski,J. R.; Johnson,S.; Gerding,D. N.Antimicrobial Agents & Chemotherapy 2007 ;51(8):2716-2719
Characterization of BctA, a mating apparatus protein required for transfer of the Bacteroides fragilis conjugal element BTF-37.Hecht,D. W.; Kos,I. M.; Knopf,S. E.; Vedantam,G.Research in microbiology 2007 ;158(7):600-607
Implementing computerized provider order entry with an existing clinical information system.Barron,W. M.; Reed,R. L.; Forsythe,S.; Hecht,D.; Glen,J.; Murphy,B.; Lach,R.; Flores,S.; Tu,J.; Concklin,M.Joint Commission Journal on Quality & Patient Safety 2006 ;32(9):506-516
Information technology. Implementing computerized provider order entry with an existing clinical information systemBarron,W. M.; Reed,R. L.; Forsythe,S.; Hecht,D.; Glen,J.; Murphy,B.; Lach,R.; Flores,S.; Tu,J.; Concklin,M.Joint Commission Journal on Quality & Patient Safety 2006 ;32(9):506-516
Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testingHecht,D. W.ANAEROBE 2006 ;12(3):115-121
Bacteroides fragilis mobilizable transposon Tn5520 requires a 71 base pair origin of transfer sequence and a single mobilization protein for relaxosome formation during conjugation.Vedantam,G.; Knopf,S.; Hecht,D. W.MOLECULAR MICROBIOLOGY 2006 ;59(1):288-300
Antibiotics and anaerobes of gut originVedantam,G.; Hecht,D. W.CURRENT OPINION IN MICROBIOLOGY 2003 ;6(5):457-461
Activities of garenoxacin (BMS-284756) and other agents against anaerobic clinical isolates.Hecht,D. W.; Osmolski,J. R.Antimicrobial Agents & Chemotherapy 2003 ;47(3):910-916
Education
Medical School
Loyola University Chicago Stritch School of Medicine
Residency
University of Minnesota Hospital and Clinics, Internal Medicine: General
Fellowship
Tufts University Affiliated Hospitals, Infectious Diseases